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Summary. Genomic imprinting is the parental-allele- 
specific expression of genes. Beckwith-Wiedemann 
syndrome (BWS), a congenital overgrowth syndrome 
with increased risk of childhood tumors, is one of the 
well-known diseases caused by imprinted genes. The 
imprinted genes causing BWS are discussed in this 
review. 
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Introduction 
Imprinted genes in mammals are exclusively 
expressed from one of the parental chromosomes (Solter, 
1988; Barlow, 1994; Efstratiadis, 1994; Nicholls, 1994; 
Ohlsson et al., 1994; Razin and Cedar, 1994). For 
example, I@ is exclusively expressed from the paternal 
allele and the maternal allele is repressed. On the 
contrary, Igf2r is exclusively expressed from the 
maternal allele and the paternal allele is repressed. The 
importance of imprinted genes in development is 
implicated in a number of genetic diseases and 
developmental failure of embryos produced by 
parthenogenesis, gynogenesis or androgenesis. 
Beckwith-Wiedemann syndrome(BWS), a con- 
genital overgrowth syndrome with an estimated 
incidence of 1113700, is one of the well-known diseases 
caused by imprinted genes. This  syndrome is  
characterized by associations of macroglossia, 
gigantism, abdominal wall defects including omphalo- 
cele and umbilical hernia, visceromegaly, earlobe 
creases or pits, renal dysplasia, facial flame nevus, hypo- 
glycemia, adrenal cytomegaly, skeletal anomalies and 
increased risk of childhood tumors including Wilms' 
tumor, adrenocortical carcinoma, rhabdomyosarcoma 
and hepatocellular carcinoma. Although most cases of 
BWS are sporadic, familial cases constitute 15%. 
Familial BWS is inherited as an autosomal dominant 
trait with incomplete penetrance and the BWS gene(s) 
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was mapped to l lp15  (Ping et al., 1989). Penetrance is 
stronger when the mother is the transmitting parent and 
cases of transmitting males with affected children are 
very rare (Lubinsky et al., 1974; Best and Hoekstra, 
1981; Moutou et al., 1992). Another 25% of cases are 
paternal disomy, which indicates replacement of the 
maternal locus with duplication of the paternal locus 
(Henry et al., 1991). The region most commonly 
involved in paternal disomy includes l lp15.  In BWS 
patients with balanced translocations and inversion of 
chromosome 11, the chromosomal aberration is of 
maternal origin (Mannens et al., 1994). These findings 
indicate that the BWS gene(s) is imprinted. 
Loss of heterozygosity at l lp15 has been observed 
in a number of human cancers including breast cancer, 
bladder, lung, ovarian, kidney and testicular carcinoma. 
Several types of childhood tumors including Wilms' 
tumor, adrenocortical carcinoma, rhabdomyosarcoma 
and hepatocellular carcinoma, display specific loss of 
maternal l l p 1 5  alleles,  suggesting that genomic 
imprinting plays an important role (Schroeder et al., 
1987; Scrable et al., 1989; Pal et al., 1990). Loss of 
imprinting of IGF2 on 11p15 has been frequently 
observed in Wilms' tumor (reveiewed by Yun, 1998). 
Mutations of the pWKIP2 gene 
The p57KIP2 gene is localized to the 11 15  
(Matsuoka et al., 1995). This gene is related to p2IE1~l 
and p27KIP2, and is a potent tight-binding inhibitor of 
several G1 cyclinlCDK complexes which control the cell 
cycle (Matsuoka et al., 1995; Mong-Hong et al., 1995). 
Overexpression of p57KIP2 arrests cells in G1, and its 
expression during development and in adults is 
correlated with terminal cellular differentiation. The 
p57KrP2 gene is imprinted and expressed predominantly 
from the maternal allele (Hatada and Mukai, 1995; 
Hatada et al., 1996a). Mutation analysis of p57K1P2 in 
BWS patients revealed mutations that alter the structure 
of the protein in 17% of cases (n=24, Hatada et al., 
1996b, 1997a). All patients were heterozygous for the 
mutant allele. In all cases where the parents were 
examined, the mothers showed mutant alleles whereas 
the father did not. Each mother was heterozygous for the 
mutant allele and the phenotype was normal. In each 



